Icon

Bunavail - (Buccal Film 6.3 mg/1 mg)

Buprenorphine and Naloxone Biodelivery Sciences
Buccal Film 6.3 mg/1 mg
Less Than $1000 mn
Less Than 5
Less Than 5
None None
None None
Indicated for the maintenance treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support.
Yes
******* ** *** ***** ** **** **** ** **** ******* '*** (*** **, ****), '*** (**** **, ****), '*** (*** **, ****) *** *** ************ *********. ** ****** **** **** ******* ****** ** **** ****. ************ **** ***** **** ** **** '*** (*** **, ****) *** *** *********.
Bunavail Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
**** ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ********* **** *, **** ******* **** *** ****** **** ****
  1. *** *, **** : ******* ******** *********** ******** *** ***** *** ***** *** **** ** **** ******* '*** (*** **, ****), '*** (**** **, ****), '*** (*** **, ****), '*** (***** **, ****)
  2. *** **, **** : **** ******** *********** ******** *** ***** ********* **** ** **** ** ****** ********* (*** **, ****),******* (**** **, ****), ******* (*** **, ****), ******* (***** **, ****)
  3. *** **, **** : *********** ******** *** ***** ***** * **** ******* ******* ** ******** ***** ** ********.
  4. *** *, **** : *********** ******** *** ***** ***** * **** ******* **** ** ******** ***** ** ********.
  5. *** **, **** : ********** ********* **** ****

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.